[{"id":"a1c4255b-9384-4488-888f-05d0a9d1efc6","acronym":"","url":"https://clinicaltrials.gov/study/NCT05851092","created_at":"2023-05-09T14:04:36.919Z","updated_at":"2024-07-02T16:35:43.591Z","phase":"Phase 1","brief_title":"Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant Tumors","source_id_and_acronym":"NCT05851092","lead_sponsor":"Shandong Suncadia Medicine Co., Ltd.","biomarkers":" HER-2 • ER","pipe":" | ","alterations":" ER positive • HER-2 negative • ER positive + HER-2 negative","tags":["HER-2 • ER"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ER positive • HER-2 negative • ER positive + HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HRS-2189"],"overall_status":"Recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 05/26/2023","start_date":" 05/26/2023","primary_txt":" Primary completion: 12/31/2025","primary_completion_date":" 12/31/2025","study_txt":" Completion: 12/31/2025","study_completion_date":" 12/31/2025","last_update_posted":"2023-07-07"}]